ReviewMolecular cancer therapeutics2016

BCL2 Inhibitors as Anticancer Drugs: A Plethora of Misleading BH3 Mimetics.

Ryan S Soderquist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.